Market closed
Maravai LifeSciences/$MRVI
14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX
About Maravai LifeSciences
Maravai LifeSciences Holdings Inc is a life sciences company. It provides products to enable the development of drug therapies, diagnostics, and novel vaccines and supports research on human diseases. Its reportable segments are Nucleic acid production and biologics safety testing. It generates a majority of its revenue from Nucleic Acid Production and focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, and therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.
Ticker
$MRVI
Sector
Trading on
Industry
Life Sciences Tools & Services
Headquarters
Employees
580
Website
MRVI Metrics
BasicAdvanced
$818M
Market cap
-
P/E ratio
-$1.66
EPS
0.02
Beta
-
Dividend rate
Price and volume
Market cap
$818M
Beta
0.02
52-week high
$11.56
52-week low
$4.28
Average daily volume
2.3M
Financial strength
Current ratio
10.738
Quick ratio
9.599
Long term debt to equity
97.839
Total debt to equity
79.237
Interest coverage (TTM)
-0.88%
Management effectiveness
Return on assets (TTM)
-1.61%
Return on equity (TTM)
-42.93%
Valuation
Price to revenue (TTM)
2.823
Price to book
1.87
Price to tangible book (TTM)
-8.47
Price to free cash flow (TTM)
-66.729
Growth
Revenue change (TTM)
-33.99%
Earnings per share change (TTM)
-989.67%
3-year revenue growth (CAGR)
-25.48%
3-year earnings per share growth (CAGR)
-29.34%
What the Analysts think about MRVI
Analyst Ratings
Analyst ratings (Buy, Hold, Sell) for Maravai LifeSciences stock.
MRVI Financial Performance
Income Statement
Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%
MRVI Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
MRVI News
AllArticlesVideos
Maravai LifeSciences Appoints R. Andrew Eckert as Chairman of the Board of Directors
GlobeNewsWire·1 week ago
Maravai LifeSciences Announces November 2024 Investor Conference Schedule
GlobeNewsWire·1 month ago
Maravai LifeSciences Holdings, Inc. (MRVI) Q3 2024 Earnings Call Transcript
Seeking Alpha·1 month ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for Maravai LifeSciences stock?
Maravai LifeSciences (MRVI) has a market cap of $818M as of December 13, 2024.
What is the P/E ratio for Maravai LifeSciences stock?
The price to earnings (P/E) ratio for Maravai LifeSciences (MRVI) stock is 0 as of December 13, 2024.
Does Maravai LifeSciences stock pay dividends?
No, Maravai LifeSciences (MRVI) stock does not pay dividends to its shareholders as of December 13, 2024.
When is the next Maravai LifeSciences dividend payment date?
Maravai LifeSciences (MRVI) stock does not pay dividends to its shareholders.
What is the beta indicator for Maravai LifeSciences?
Maravai LifeSciences (MRVI) has a beta rating of 0.02. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.